doi: 10.1172/jci.insight.133429
The selected per-injection dose remains fixed at 1.64.8 mg across all three phases, while frequency changes from daily to 5 per week to 23 per week for maintenance, followed by 48 weeks off
This means it acts on two hormonal pathways involved in metabolism and appetite
GLP-1RA can induce glucose-dependent stimulation of insulin secretion, reduce glucagon release, reduce hepatic glucose output, delay gastric emptying and increase satiety, resulting in moderate reductions in glycated hemoglobin (HbA1c), body weight and systolic blood pressure, the risk of hypoglycemia is lower
Fluid needs vary from person to person
Ozempic is provided in a prefilled multi-dose disposable pen, which contains the drug solution, semaglutide, in a 1.5 mL or 3 mL cartridge